SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved OCREVUS™ ...

On Wednesday, Ward Room reported on the formation of the Progressive Reform Caucus, made up of nine aldermen with records of defying Mayor Rahm Emanuel. It already has competition on the left wing of ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

EXTON, Pa., June 26, 2018 /PRNewswire/ -- Largely fueled by Genentech's Ocrevus availability, a paradigm shift has occurred in the US multiple sclerosis (MS) market resulting in increased rates of ...

AB Science SA (Euronext - FR0010557264 - AB) today provides an update on the development of masitinib in progressive forms of multiple sclerosis (MS), following the European Committee for Treatment ...

The role of imaging in diagnosing progressive multiple sclerosis (MS) and in assessing prognosis is the subject of a new review. MRI is central in the diagnostic workup of patients suspected of having ...

More than 20 years ago, as Jennifer Digmann focused on completing her coursework and graduating from college, she began experiencing numbness in her hands and feet and eventually double vision. After ...

The mAb is the first approved treatment that targets the progressive form of the disease. Most of the existing treatments for relapsing multiple sclerosis (MS) and primary progressive MS (PPMS) work ...

FIRST ON FOX: A prominent left-wing dark money nonprofit poured nearly $150 million in secret cash into progressive groups and causes in 2022, tax forms obtained by Fox News Digital show. The Sixteen ...

As third-party cookies come to an end, brands are focusing on collecting more zero-party data directly from their customers and prospects so they can better understand their needs and wants. Although ...